Fortress Biotech, Inc. (FBIO)

Nasdaq: FBIO · Pharmaceutical Preparations · Bay Harbor Islands, FL · filing with the SEC since 2008

Grade5.1

◀ Past 5.0● Present 5.9▶ Future 4.3

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 31, 2026	Mar 31, 2025	Mar 28, 2024	Mar 31, 2023	Mar 28, 2022	Mar 31, 2021	Mar 16, 2020	Mar 18, 2019	Mar 16, 2018	Mar 16, 2017
Revenue	63,262,000	57,675,000	84,513,000	75,743,000	68,791,000	45,599,000	36,629,000	26,882,000	17,245,000^r	16,480,000
For lenders
Net interest income	·	·	·	·	·	·	11,849	10,340	7,687	·
Cost of revenue	20,924,000	20,879,000	22,893,000^r	30,775,000	32,084,000	14,594,000	10,532,000	6,125,000	3,658,000	790,000^r
Research and development	11,901,000	56,629,000	101,747,000	134,199,000	113,240,000	61,275,000^r	6,090,000^r	83,333,000	48,322,000^r	35,134,000^r
Selling, general and administrative	96,400,000	87,731,000	90,981,000^r	113,656,000	86,843,000	61,166,000	55,590,000	53,371,000	·	·
Sales and marketing	·	·	·	·	·	17,384,000	17,120,000	11,639,000	10,410,000	5,774,000
General and administrative	·	·	·	·	·	43,782,000	38,470,000	41,732,000^r	50,897,000^r	28,229,000^r
Total operating expenses	·	·	·	·	·	·	·	146,879,000	107,041,000^r	82,190,000
Total costs and expenses	133,483,000	168,054,000	226,855,000	279,307,000	257,332,000	139,869,000	147,448,000	146,879,000	·	·
Operating income	-70,221,000	-110,379,000	-142,342,000	-203,564,000	-188,541,000	-94,270,000	-110,819,000	-119,997,000	-89,796,000^r	-65,710,000
Interest expense	10,106,000	13,527,000	15,315,000	12,482,000	15,308,000	15,326,000	11,849,000	·	5,860,000	3,690,000
Interest and investment income	2,485,000	2,683,000	3,003,000	1,398,000	649,000	1,518,000	2,559,000	1,104,000	819,000	298,000
Interest income (expense), net	·	·	·	·	·	·	8,528	7,921,000^r	4,442	·
Other income (expense), net	17,578,000	1,318,000	-3,403,000	1,215,000	·	·	·	·	·	·
Total non-operating income (expense)	36,686,000	-10,164,000	-11,291,000	-9,900,000	24,188,000	-8,579,000	9,159,000	-10,803,000	-7,717,000^r	-5,580,000
Income before income taxes	-33,535,000	-120,543,000	-153,633,000	-213,464,000	-164,353,000	-102,849,000	-101,660,000	-130,800,000	-97,513,000^r	-71,290,000
Income tax expense	-620,000	312,000	521,000	449,000	473,000	500,000^r	0	0	1,513,000	0
Income from discontinued operations	·	·	·	·	·	·	0	-11,136,000	-2,323,000	·
Net income including non-controlling interests	-32,915,000	-120,855,000	-154,154,000	-213,913,000	-164,826,000	-102,985,000	-101,660,000	-141,936,000	-99,836,000	-71,290,000
Net income to non-controlling interests	-39,730,000	-74,858,000	-93,517,000	-127,338,000	-100,123,000	-56,459,000	-61,700,000	-57,789,000	-32,960,000	-16,195,000
Net income	6,815,000	-45,997,000	-60,637,000	-86,575,000	-64,703,000	-46,526,000	-39,960,000	-84,147,000	-66,876,000	-55,095,000
Net income to common shareholders	-1,882,000	-55,890,000	-68,669,000	-94,607,000	·	·	·	·	·	·
Earnings per share, basic	-0.07	-2.69	-8.47	-15.97^r	-0.79	·	·	·	·	·
Earnings per share, diluted	-0.07	-2.69	-8.47	-15.97^r	-0.79	·	·	·	·	·
Earnings per share, basic and diluted	·	·	·	·	-0.79	-0.65	-0.73	-1.94	-1.61	-1.38
Weighted average shares, basic	27,901,889	20,784,334	8,110,906	5,924,967^r	81,700,220	·	·	·	·	·
Weighted average shares, diluted	27,901,889	20,784,334	8,110,906	5,924,967^r	81,700,220	·	·	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	81,700,220	72,005,181	54,711,838	43,461,978	41,658,733	39,962,657

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldus-gaap:Revenues

Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold

Research and development spent on inventing what it sells next

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseDebt
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before tax

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton FBIO · research, not advice